000			02123 a2200613 4500
005			20250516054821.0
264		0	_c20120511
008			201205s 0 0 eng d
022			_a1538-8514
024	7		_a10.1158/1535-7163.MCT-11-0264 _2doi
040			_aNLM _beng _cNLM
100	1		_aYakes, F Michael
245	0	0	_aCabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth. _h[electronic resource]
260			_bMolecular cancer therapeutics _cDec 2011
300			_a2298-308 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiogenesis Inhibitors _xpharmacology
650	0	4	_aAnilides _xpharmacology
650	0	4	_aAnimals
650	0	4	_aCell Growth Processes _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aModels, Biological
650	0	4	_aNeoplasm Metastasis _xprevention & control
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aNeovascularization, Pathologic _xdrug therapy
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-met _xantagonists & inhibitors
650	0	4	_aPyridines _xpharmacology
650	0	4	_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors
700	1		_aChen, Jason
700	1		_aTan, Jenny
700	1		_aYamaguchi, Kyoko
700	1		_aShi, Yongchang
700	1		_aYu, Peiwen
700	1		_aQian, Fawn
700	1		_aChu, Felix
700	1		_aBentzien, Frauke
700	1		_aCancilla, Belinda
700	1		_aOrf, Jessica
700	1		_aYou, Andrew
700	1		_aLaird, A Douglas
700	1		_aEngst, Stefan
700	1		_aLee, Lillian
700	1		_aLesch, Justin
700	1		_aChou, Yu-Chien
700	1		_aJoly, Alison H
773	0		_tMolecular cancer therapeutics _gvol. 10 _gno. 12 _gp. 2298-308
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-11-0264 _zAvailable from publisher's website
999			_c21165066 _d21165066